ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 244,72
0,36%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Icad Inc (ICAD)

  7. Icad Inc (ICAD) Actualités

ICAD Icad Inc

1,57
0,02 (1,29%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Icad Inc ICAD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,02 1,29% 1,57 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,52 1,50 1,56 1,52 1,55
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
14/6/202422:31EDGAR2Form 8-K - Current report
04/6/202414:00GLOBEiCAD to Participate in the MedInvest MedTech, AI & Digital..
15/5/202414:00GLOBEiCAD Reports Financial Results for First Quarter Ended March..
08/5/202415:49GLOBEUPDATE - iCAD to Report First Quarter 2024 Financial Results..
02/5/202414:00GLOBEiCAD to Report First Quarter 2024 Financial Results on May..
11/4/202414:00GLOBEiCAD Showcases New ProFound Cloud, Enhanced ProFound..
09/4/202414:00GLOBEiCAD and Densitas Partner to Enhance Precision Breast Health..
08/4/202422:29GLOBEiCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk..
03/4/202414:00GLOBEiCAD Partners with RAD-AID to Advance Breast Cancer..
02/4/202414:00GLOBEiCAD Unveils ProFound Cloud, Enabling Interoperability and..
19/3/202414:00GLOBEiCAD Releases Enhanced ProFound Detection Workstation..
12/3/202421:01GLOBEiCAD Announces Fiscal Fourth Quarter and Full-Year 2023..
28/2/202414:05GLOBEiCAD Highlights Promising Clinical Data Demonstrating..
27/2/202415:05GLOBEiCAD expands Board of Directors with the appointment of Dr...
27/2/202414:05GLOBEiCAD to Report Fourth Quarter and Full Year 2023 Financial..
26/2/202423:16EDGAR2Form 8-K - Current report
26/2/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/2/202415:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202414:00GLOBEiCAD to Participate in the BTIG at Snowbird: 11th Annual..
30/1/202414:00GLOBEiCAD Expands Board of Directors with Appointment of Michael..
26/1/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:15EDGAR2Form 8-K - Current report
17/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202402:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202319:37EDGAR2Form 144 - Report of proposed sale of securities
18/12/202314:00GLOBEiCAD Expands Executive Sales Leadership Team as Business..
28/11/202314:00GLOBEiCAD’s AI-powered solutions to Help Accelerate Breast Cancer..
27/11/202314:00GLOBEiCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast..
20/11/202314:00GLOBEiCAD and CancerIQ Announce Partnership to Integrate..
14/11/202314:00GLOBEiCAD to Participate in the 14th Annual Craig-Hallum Alpha..
13/11/202322:29EDGAR2Form 8-K - Current report
13/11/202322:01GLOBEiCAD Reports Financial Results for Third Quarter Ended..
07/11/202322:05EDGAR2Form 8-K - Current report
01/11/202321:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202313:00GLOBEiCAD to Report Third Quarter 2023 Financial Results on..
23/10/202314:35EDGAR2Form 8-K - Current report
23/10/202314:01GLOBEiCAD, Inc. Announces Sale of Xoft, its Brachytherapy..
16/8/202314:00GLOBEHealth Canada Grants Device License for iCAD's ProFound Risk..
14/8/202322:05EDGAR2Form 8-K - Current report
14/8/202322:01GLOBEiCAD Reports Financial Results for Second Quarter Ended June..
14/8/202314:00GLOBEiCAD and Google Health Expand Integration of Google’s AI..
11/8/202322:58EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/8/202322:49EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202301:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
ICAD
Icad
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés